118 related articles for article (PubMed ID: 9367882)
1. The antidiabetic agent thiazolidinedione stimulates the interaction between PPAR gamma and CBP.
Mizukami J; Taniguchi T
Biochem Biophys Res Commun; 1997 Nov; 240(1):61-4. PubMed ID: 9367882
[TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferator-activated receptor-gamma activation by thiazolidinediones induces adipogenesis in bone marrow stromal cells.
Gimble JM; Robinson CE; Wu X; Kelly KA; Rodriguez BR; Kliewer SA; Lehmann JM; Morris DC
Mol Pharmacol; 1996 Nov; 50(5):1087-94. PubMed ID: 8913339
[TBL] [Abstract][Full Text] [Related]
3. Induction of the nuclear orphan receptor RORgamma during adipocyte differentiation of D1 and 3T3-L1 cells.
Austin S; Medvedev A; Yan ZH; Adachi H; Hirose T; Jetten AM
Cell Growth Differ; 1998 Mar; 9(3):267-76. PubMed ID: 9543393
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor alpha and interleukin 11 secreted by malignant breast epithelial cells inhibit adipocyte differentiation by selectively down-regulating CCAAT/enhancer binding protein alpha and peroxisome proliferator-activated receptor gamma: mechanism of desmoplastic reaction.
Meng L; Zhou J; Sasano H; Suzuki T; Zeitoun KM; Bulun SE
Cancer Res; 2001 Mar; 61(5):2250-5. PubMed ID: 11280794
[TBL] [Abstract][Full Text] [Related]
5. Suppression of PPAR-gamma attenuates insulin-stimulated glucose uptake by affecting both GLUT1 and GLUT4 in 3T3-L1 adipocytes.
Liao W; Nguyen MT; Yoshizaki T; Favelyukis S; Patsouris D; Imamura T; Verma IM; Olefsky JM
Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E219-27. PubMed ID: 17389706
[TBL] [Abstract][Full Text] [Related]
6. Negative regulation of peroxisome proliferator-activated receptor-gamma gene expression contributes to the antiadipogenic effects of tumor necrosis factor-alpha.
Zhang B; Berger J; Hu E; Szalkowski D; White-Carrington S; Spiegelman BM; Moller DE
Mol Endocrinol; 1996 Nov; 10(11):1457-66. PubMed ID: 8923470
[TBL] [Abstract][Full Text] [Related]
7. A selective peroxisome proliferator-activated receptor gamma modulator with distinct fat cell regulation properties.
Fujimura T; Kimura C; Oe T; Takata Y; Sakuma H; Aramori I; Mutoh S
J Pharmacol Exp Ther; 2006 Aug; 318(2):863-71. PubMed ID: 16682454
[TBL] [Abstract][Full Text] [Related]
8. Novel genes regulated by the insulin sensitizer rosiglitazone during adipocyte differentiation.
Albrektsen T; Frederiksen KS; Holmes WE; Boel E; Taylor K; Fleckner J
Diabetes; 2002 Apr; 51(4):1042-51. PubMed ID: 11916924
[TBL] [Abstract][Full Text] [Related]
9. Role of peroxisome proliferator-activated receptor-gamma in maintenance of the characteristics of mature 3T3-L1 adipocytes.
Tamori Y; Masugi J; Nishino N; Kasuga M
Diabetes; 2002 Jul; 51(7):2045-55. PubMed ID: 12086932
[TBL] [Abstract][Full Text] [Related]
10. Overexpression and ribozyme-mediated targeting of transcriptional coactivators CREB-binding protein and p300 revealed their indispensable roles in adipocyte differentiation through the regulation of peroxisome proliferator-activated receptor gamma.
Takahashi N; Kawada T; Yamamoto T; Goto T; Taimatsu A; Aoki N; Kawasaki H; Taira K; Yokoyama KK; Kamei Y; Fushiki T
J Biol Chem; 2002 May; 277(19):16906-12. PubMed ID: 11884404
[TBL] [Abstract][Full Text] [Related]
11. PAT5A: a partial agonist of peroxisome proliferator-activated receptor gamma is a potent antidiabetic thiazolidinedione yet weakly adipogenic.
Misra P; Chakrabarti R; Vikramadithyan RK; Bolusu G; Juluri S; Hiriyan J; Gershome C; Rajjak A; Kashireddy P; Yu S; Surapureddi S; Qi C; Zhu YJ; Rao MS; Reddy JK; Ramanujam R
J Pharmacol Exp Ther; 2003 Aug; 306(2):763-71. PubMed ID: 12730351
[TBL] [Abstract][Full Text] [Related]
12. 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma.
Forman BM; Tontonoz P; Chen J; Brun RP; Spiegelman BM; Evans RM
Cell; 1995 Dec; 83(5):803-12. PubMed ID: 8521497
[TBL] [Abstract][Full Text] [Related]
13. [PPAR gamma: a major nuclear receptor in adipogenesis].
Gervois P; Fruchart JC
Med Sci (Paris); 2003 Jan; 19(1):20-2. PubMed ID: 12836187
[No Abstract] [Full Text] [Related]
14. A new selective peroxisome proliferator-activated receptor gamma antagonist with antiobesity and antidiabetic activity.
Rieusset J; Touri F; Michalik L; Escher P; Desvergne B; Niesor E; Wahli W
Mol Endocrinol; 2002 Nov; 16(11):2628-44. PubMed ID: 12403851
[TBL] [Abstract][Full Text] [Related]
15. The short- and long-term effects of tumor necrosis factor-alpha and BRL 49653 on peroxisome proliferator-activated receptor (PPAR)gamma2 gene expression and other adipocyte genes.
Rosenbaum SE; Greenberg AS
Mol Endocrinol; 1998 Aug; 12(8):1150-60. PubMed ID: 9717841
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of adipogenesis by a COOH-terminally truncated mutant of PPARgamma2 in 3T3-L1 cells.
Masugi J; Tamori Y; Kasuga M
Biochem Biophys Res Commun; 1999 Oct; 264(1):93-9. PubMed ID: 10527847
[TBL] [Abstract][Full Text] [Related]
17. A new thiazolidinedione, NC-2100, which is a weak PPAR-gamma activator, exhibits potent antidiabetic effects and induces uncoupling protein 1 in white adipose tissue of KKAy obese mice.
Fukui Y; Masui S; Osada S; Umesono K; Motojima K
Diabetes; 2000 May; 49(5):759-67. PubMed ID: 10905484
[TBL] [Abstract][Full Text] [Related]
18. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma).
Lehmann JM; Moore LB; Smith-Oliver TA; Wilkison WO; Willson TM; Kliewer SA
J Biol Chem; 1995 Jun; 270(22):12953-6. PubMed ID: 7768881
[TBL] [Abstract][Full Text] [Related]
19. Gene expression profile of adipocyte differentiation and its regulation by peroxisome proliferator-activated receptor-gamma agonists.
Gerhold DL; Liu F; Jiang G; Li Z; Xu J; Lu M; Sachs JR; Bagchi A; Fridman A; Holder DJ; Doebber TW; Berger J; Elbrecht A; Moller DE; Zhang BB
Endocrinology; 2002 Jun; 143(6):2106-18. PubMed ID: 12021175
[TBL] [Abstract][Full Text] [Related]
20. Synergistic potentiation of thiazolidinedione-induced ST 13 preadipocyte differentiation by RAR synergists.
Sato M; Yajima Y; Kawashima S; Tanaka K; Kagechika H
Biochem Biophys Res Commun; 2001 Jan; 280(3):646-51. PubMed ID: 11162570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
